diphtheria

Documents about diphtheria

• Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine#121425ClinicalTrials.gov
• Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines#121444ClinicalTrials.gov
• Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®#123563ClinicalTrials.gov
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults#343700ClinicalTrials.gov
• Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea#343702ClinicalTrials.gov
• Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines#346974ClinicalTrials.gov
• Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine#353342ClinicalTrials.gov
• Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine#356518ClinicalTrials.gov
• A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers#356533ClinicalTrials.gov
• Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants#363650ClinicalTrials.gov

Related topics